Skip to main content
Ritu Salani, MD, Obstetrics & Gynecology, Los Angeles, CA

RituSalaniMDMBA

Obstetrics & Gynecology Los Angeles, CA

Gynecologic Oncology

Professor, Obstetrics and Gynecology, University of California, Los Angeles

Dr. Salani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Salani's full profile

Already have an account?

  • Office

    200 UCLA Medical Plz
    Los Angeles, CA 90095
    Phone+1 310-794-7274
    Fax+1 310-794-7274

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Gynecologic Oncology, 2005 - 2008
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Obstetrics and Gynecology, 2001 - 2005
  • Northeast Ohio Medical University
    Northeast Ohio Medical UniversityClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2020 - 2026
  • OH State Medical License
    OH State Medical License 2008 - 2022
  • MD State Medical License
    MD State Medical License 2006 - 2009
  • GA State Medical License
    GA State Medical License 2003 - 2005
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • An Ecological Evaluation of the Increasing Incidence of Endometrial Cancer and the Obesity Epidemic  
    Stacy A Smrz, Corinne Calo, Ritu Salani, American Journal of Obstetrics and Gynecology

Authored Content

  • Disappointing but Important: Cervical Cancer OUTBACK Trial’s Negative ResultsJune 2021

Press Mentions

  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer
    CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian CancerMarch 26th, 2023
  • Nykode Therapeutics Announces Collaboration with the GOG Foundation, Inc. To Conduct the VB-C-04 Trial in Advanced Cervical Cancer
    Nykode Therapeutics Announces Collaboration with the GOG Foundation, Inc. To Conduct the VB-C-04 Trial in Advanced Cervical CancerFebruary 10th, 2023
  • Cervical Health Awareness Month Brings Attention to Necessary Screenings
    Cervical Health Awareness Month Brings Attention to Necessary ScreeningsJanuary 30th, 2023
  • Join now to see all

Professional Memberships